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morphometry to dissect the effect of NG2 KO on CNS 
pathology. NG2KO mice developed milder EAE than 
their wild-type (WT) counterparts, with less intense neu-
ropathology associated with a significant improvement 
in BBB stability. In contrast to WT mice, OPC numbers 
did not change in NG2KO mice during EAE. Through 
FACS and confocal microscopy, we found that NG2 was 
also expressed by immune cells, including T cells, mac-
rophages, and dendritic cells (DCs). Assessment of recall 
T cell responses to the encephalitogen by proliferation 
assays and ELISA showed that, while WT and NG2KO T 
cells proliferated equally to the encephalitogenic peptide 
MOG35-55, NG2KO T cells were skewed towards a Th2-
type response. Because DCs could be responsible for this 
effect, we assessed their expression of IL-12 by PCR and 
intracellular FACS. IL-12-expressing CD11c+ cells were 
significantly decreased in MOG35-55-primed NG2KO 
lymph node cells. Importantly, in WT mice, the propor-
tion of IL-12-expressing cells was significantly lower 
in CD11c+ NG2- cells than in CD11c+ NG2+ cells. 
To assess the relevance of NG2 at immune system and 
CNS levels, we induced EAE in bone-marrow chimeric 
mice, generated with WT recipients of NG2KO bone-
marrow cells and vice versa. Regardless of their original 
phenotype, mice receiving NG2KO bone marrow devel-
oped milder EAE than those receiving WT bone marrow. 
Our data suggest that NG2 plays a role in EAE not only 
at CNS/BBB level, but also at immune response level, 
impacting on DC activation and thereby their stimulation 
of reactive T cells, through controlling IL-12 expression.
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Abstract In adult CNS, nerve/glial-antigen 2 (NG2) is 
expressed by oligodendrocyte progenitor cells (OPCs) 
and is an early marker of pericyte activation in pathologi-
cal conditions. NG2 could, therefore, play a role in exper-
imental autoimmune encephalomyelitis (EAE), a disease 
associated with increased blood–brain barrier (BBB) 
permeability, inflammatory infiltrates, and CNS damage. 
We induced EAE in NG2 knock-out (NG2KO) mice and 
used laser confocal microscopy immunofluorescence and 
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Introduction
The nerve/glial antigen 2 (NG2; also known as chondroi-
tin sulfate proteoglycan 4, CSPG4) is a chondroitin sulfate 
proteoglycan expressed by a number of cell types within 
and outside the central nervous system (CNS). Within the 
CNS, NG2, together with platelet-derived growth factor 
receptor alpha (PDGFRα), is a marker of oligodendrocyte 
precursor cells (OPCs), which downregulate both mark-
ers as they differentiate into mature oligodendrocytes [16, 
28, 39, 47]. The OPCs respond with increased prolifera-
tion to CNS injury and large numbers of NG2-expressing 
cells are found at sites of inflammation in the CNS [10]. In 
particular, OPC levels markedly increase at the acute phase 
of experimental autoimmune encephalomyelitis (EAE), 
the purported model for multiple sclerosis [16, 19], but are 
severely decreased in chronic EAE [16]. These cells have 
been shown to respond to demyelination by generating new 
oligodendrocytes [19, 27, 50, 55]. At the CNS microves-
sels, pericytes are involved in ensheathment of endothelial 
cells, blood–brain barrier (BBB)-endothelial cell differenti-
ation, and maintenance of adult endothelial barrier function 
[2, 23]. Although NG2 is not expressed in adult CNS peri-
cytes [53], it is an early marker of pericyte activation dur-
ing CNS development and pathological conditions [40, 53]. 
Thus, upon CNS injury, NG2-reactive pericytes are found 
along microvessels, where they act as sensors for inflam-
mation and support the immunosurveillance and effector 
function of extravasated neutrophils and macrophages [48]. 
Non-CNS resident infiltrating macrophages that express 
NG2 have also been observed in CNS inflammation [5, 33], 
but, to date, the expression of NG2 on other immune cell 
subsets has not been reported.
These observations suggest a role for NG2 in CNS 
injury associated with inflammation, a possibility corrobo-
rated by the accumulation of NG2 at the glial scar, due not 
only to the recruitment of OPCs, but also to the shedding 
of the extracellular domain of NG2 from OPCs and to its 
incorporation into the extracellular matrix [3, 9]. Moreo-
ver, there is controversial evidence for a role of NG2 in 
axon regeneration, remyelination, and CNS recovery [10]. 
Thus, in vitro studies have shown that NG2 inhibits neurite 
growth, suggesting that it could inhibit axonal regeneration 
[49, 52]. In contrast, other studies both in vitro [57] and 
in vivo [9, 24] suggest that NG2 is unlikely to be a major 
inhibitor of axonal regeneration after CNS injury.
On the basis of the above data, it appears highly likely 
that NG2 could play a role in EAE, a disease associated 
with increased BBB permeability, inflammatory infiltrates, 
and CNS damage. Moransard et al. studied EAE in NG2 
knock-out (KO) mice to assess this possibility and did not 
observe any difference at clinical, immune response, and 
pathological levels, between NG2KO and wild-type mice 
[35]. In this study, we investigated EAE in NG2KO mice of 
the same origin [17] and found, in contrast, that NG2 plays 
an important role in EAE, with NG2 KO resulting in a sig-
nificantly milder EAE disease, at clinical and neuropatho-
logical levels. Unexpectedly, we observed that NG2 signifi-
cantly contributes to EAE pathogenesis and progression, 
not only through its expression on CNS-resident OPCs and 
pericytes, but also through its expression on immune cells, 
which had not been reported and studied previously, in par-
ticular at the encephalitogenic T cells/dendritic cells axis.
Materials and methods
Mice
Wild-type C57Bl/6J mice were purchased from Harlan 
(Bresso, Italy). The homozygous NG2−/− mouse colony 
was generated as follows: NG2 knock-out (NG2KO) 
mice, developed by Stallcup and colleagues [17] on the 
C57BL/6J background and kindly provided by Prof. Malat-
esta (University of Genoa, Italy), were cross-bred with 
WT C57Bl/6J mice and the F1 heterozygous NG2+/− mice 
were themselves crossed to obtain homozygous NG2−/− F2 
progeny. The NG2−/− (NG2KO) mice were then interbred 
to maintain the homozygous colony and used for all experi-
ments. NG2KO mice were regularly genotyped by PCR 
to ensure the maintenance of the insertion leading to gene 
disruption (Supplementary Fig. S1). The F2 NG2+/+ mice 
were themselves interbred to generate “wild-type” (WT) 
control mice. NG2KO mice were viable, healthy, fertile, 
and indistinguishable from WT mice. All mice were housed 
in pathogen-free conditions with food and water ad libitum. 
All applicable international, national, and/or institutional 
guidelines for the care and use of animals were followed 
(Decreto Legislativo 4 marzo 2014, n. 26, legislative trans-
position of Directive 2010/63/EU of the European Par-
liament and of the Council of 22 September 2010 on the 
protection of animals used for scientific purposes). The 
research protocol was approved by the Ethical Committee 
for Animal Experimentation of the University of Genoa, 
Italy.
EAE induction
Chronic EAE was induced in female WT and NG2KO mice 
(6–8 weeks of age, weighing 18.5 ± 1.5 g) by subcuta-
neous injection at two different sites in the right and left 
flanks and one site at the tail base with an emulsion (300 µl 
total) containing 200 µg myelin oligodendrocyte glyco-
protein peptide spanning amino acids 35–55 (MOG35–
55) (Espikem) in incomplete Freund’s adjuvant (Sigma-
Aldrich) supplemented with 300 µg Mycobacterium 
25Acta Neuropathol (2016) 132:23–42 
1 3
tuberculosis (strain H37RA; Difco). Mice were injected in 
the tail vein with 400 ng pertussis toxin (Sigma-Aldrich) 
in 100 µl of phosphate buffer saline solution (PBS, pH 7.6) 
immediately, and 48 h after the immunization. The mice 
were scored daily for clinical manifestations of EAE on a 
scale of 0–5 [59].
Immunohistochemistry
Mice under deep anesthesia with ketamine/xylazine cock-
tail (90 mg and 4.5 mg/kg, respectively; intraperitoneal 
injection) were transcardially perfused with 100–150 ml 
of 2 % paraformaldehyde (PFA) and 0.2 % glutaralde-
hyde (Sigma-Aldrich) solution. Whole brains and spinal 
cords were removed and post-fixed by immersion in the 
same fixative at 4 °C for 4 h, then washed in PBS over-
night at 4 °C, and the samples were stored in 0.2 % PFA 
in PBS at 4 °C. Spinal cord demyelination and inflamma-
tory activity were evaluated as previously described [14, 
59]. Briefly, demyelination was measured as the percent 
of demyelinated areas in the area of entire section of the 
spinal cord as follows: for each mouse (n = 5 mice per 
group), three sections per each of cervical, thoracic, and 
lumbar regions were stained with Luxol Fast Blue and 
demyelination was scored as follows: 1 = traces of subpial 
demyelination; 2 = marked subpial and perivascular demy-
elination; 3 = confluent perivascular or subpial demyelina-
tion; 4 = massive perivascular and subpial demyelination 
involving one half of the spinal cord with presence of cel-
lular infiltrates in the CNS parenchyma; and 5 = exten-
sive perivascular and subpial demyelination involving the 
whole cord section with presence of cellular infiltrates in 
the CNS parenchyma. In chimeric mice (see below), demy-
elination was assessed by staining for myelin basic protein 
(MBP) with anti-MBP antibody (diluted 1:90, Abcam). 
The inflammatory activity was analyzed by immunohis-
tochemistry with anti–mouse CD3 (diluted 1:200, Santa 
Cruz) and anti–mouse IBA-1 (diluted 1:500, Abcam) anti-
bodies, which identify T cells and microglia/macrophages, 
respectively. We used antibodies against glial fibrillary 
acidic protein (GFAP, diluted 1:500, Agilent Technologies) 
for the detection of astrocytes, and against inducible nitric 
oxide synthase (iNOS, diluted 1:100, Abcam) as inflamma-
tory activity marker. All primary antibodies were detected 
with a biotin- or rhodamine-labeled secondary antibody 
(Bio-Rad) followed by diaminobenzidine-tetrahydrochlo-
ride detection according to standard protocol. Quantifica-
tion was performed for the same areas as for demyelina-
tion in sequential sections of the same spinal cord regions, 
i.e., nine sections per animal, from approximately three 
segments apart. Images were captured at 40× magnifica-
tion with an Axio Imager M1 microscope and analyzed 
with AxioCam software (Zeiss). The captured images 
were coded and quantified in a blinded manner. Data are 
expressed as mean ± standard error of the mean (SEM) 
of the total number of positive elements exclusively in the 
white matter and reported as number of positive elements 
per mm2.
To assess NG2 expression on immune cells, spleno-
cytes were seeded onto poly-lysine-coated glass coverslips 
and then placed in 24-well plates in RPMI1640 (Thermo 
Fisher Scientific), 1 mM glutamine (Thermo Fisher Sci-
entific), 2-mercaptoethanol (5 × 10−5 M, Sigma-Aldrich), 
penicillin/streptomycin (50 U/ml, Thermo Fisher Scien-
tific), supplemented with 10 % fetal bovine serum (FBS, 
Thermo Fisher Scientific). After overnight incubation, cells 
were fixed with 4 % PFA and processed for immunocyto-
fluorescence with rabbit anti-NG2 (diluted 1:150, Merck), 
anti-CD11b (diluted 1:100, Merck), anti-CD11c (diluted 
1:200, Merck), and anti-CD3 (diluted 1:50, Santa Cruz) 
antibodies. Primary antibody binding was detected with 
the appropriate secondary antibody: IgG anti-rabbit FITC-
conjugated for anti-NG2 and IgG anti-rabbit PE-conjugated 
for anti-CD11b, anti-CD11c, and anti-CD3 (diluted 1:100, 
Thermo Fisher Scientific). The reactivities were detected 
under an Axio Imager.M1 microscope and analyzed with 
AxioCam software (Zeiss).
Laser confocal microscopy immunofluorescence
These methods are essentially similar to what we previ-
ously described [11]. Briefly, the perfused brains and spinal 
cords were serially sectioned using a vibrating microtome 
(Leica) in about 120 serial sections (20 µm-thick) per sam-
ple and organized in a multiwell archive stored at 4 °C. 
Single and multiple immunostainings were carried out 
with the following primary antibodies: anti-CD45 (diluted 
1:50; Novus Biologicals), anti-collagen type IV (Coll IV; 
diluted 1:50; Acris Antibodies GmbH), anti-PDGFRα 
(diluted 1:70; Millipore), anti-G-protein coupled receptor 
17 (GPR17, diluted 1:350; Cayman Chemical), anti-Alz-
heimer precursor protein A4 (APP; diluted 1:100; Milli-
pore), anti-MBP (diluted 1:90, Abcam), anti-CD13 (diluted 
1:50; Aminopeptidase N; BD Pharmigen), anti-Claudin-5 
(diluted 1:25; Invitrogen), anti-occludin (diluted 1:50; Inv-
itrogen), anti-NG2 (diluted 1:200; Merck), and anti IBA-1 
(diluted 1:50; Abcam) antibodies, then detected by appro-
priate fluorophore-conjugated (Alexa Fluor® 488, 555 and 
568; Invitrogen) or biotinylated (Vector Laboratories) sec-
ondary antibodies and fluorophore-conjugated streptavidin 
(Invitrogen) diluted in PBS containing 1 % bovine albu-
min and 2 % FBS. After immmunolabeling, the sections 
were counterstained with TO-PRO-3 (Alexa Fluor® 633; 
diluted 1:10 in PBS; Invitrogen). Negative controls were 
prepared by omitting the primary antibodies, pre-adsorb-
ing the primary antibodies with an excess of antigen when 
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available, and mismatching the secondary antibodies. The 
sections were examined under a Leica TCS SP5 confocal 
laser-scanning microscope (Leica Microsystems) using 
a sequential scan procedure. Confocal images were taken 
at 250–500 nm intervals through the z-axis of the sections 
with 40× and 63× oil lenses.
Laser confocal microscopy morphometry
Quantitative assessment of PDGFRα+ OPCs, GPR17+ pre-
myelinating oligodendrocytes, and MBP+APP+ axons was 
carried out through computer-aided morphometric analysis 
with Leica Confocal Multicolor Package (Leica Microsys-
tems) and ImageJ software. Randomly chosen fields across 
the cerebral cortex and spinal cord white matter were ana-
lyzed for each mouse on 4 sections per brain and 3 sec-
tions per each of cervical, thoracic, and lumbar spinal cord 
regions. The number of positive cells and APP+ trans-
versely cut axons was interactively counted (Cell counter 
ImageJ) on serial 0.5 μm optical sections across the entire 
stack of the projection images (20 μm thick). The results 
for the cells were normalized to the same volume (1 mm3), 
whereas the results for axons were normalized to a bi-
dimensional value (reference area = 1 mm2).
FITC‑dextran injection
Mice were injected with a solution of heparin (100 Units/
kg) containing 71-kDa FITC-labeled dextran (5 mg/ml, 
Sigma-Aldrich) into the tail vein. Two minutes later, the 
mice under deep anesthesia with ketamine/xylazine cock-
tail (90 mg and 4.5 mg/kg, respectively; intraperitoneal 
injection) were killed, and brain and spinal cord were col-
lected immediately. The tissues were processed by post-
fixation as described above, and 20-µm-thick slices were 
counterstained with TO-PRO3 (Alexa Fluor® 633, diluted 
1:10 in PBS; Invitrogen) and analyzed by confocal micros-
copy (Leica Microsystems) with 40× oil lens.
T‑cell proliferation assay
For the measurement of WT and NG2KO ex vivo prolif-
erative responses, mice were immunized with MOG35-
55 using the same protocol as for EAE induction, except 
that they did not receive pertussis toxin, and lymph node 
cells were isolated from the draining inguinal lymph nodes 
9 days after immunization. MOG35–55-primed lymph 
node cells were cultured (2 × 105 cells/well) in 96-well 
flat-bottom plates in the presence of 10 μg/ml MOG35–55, 
1 μg/ml Concanavalin A (ConA, Sigma-Aldrich) as posi-
tive control, or 10 µg/ml proteolipid protein peptide span-
ning amino acids 139–151 (PLP), as negative control, for 
3 days. Irradiated (25 Gy) splenocytes, isolated from the 
spleen of the same MOG-immunized mice and depleted of 
T cells through negative selection (Pan T cell Isolation Kit 
II, Miltenyi), were used as supplementary antigen-present-
ing cells (1 × 106 cells/well). Cell proliferation was meas-
ured as DNA incorporation of 5-ethynyl-2′-deoxyuridine 
(EdU) with Click-iT® EdU Microplate Assay (Thermo 
Fisher Scientific).
Elisa
Cytokines were evaluated in supernatants from MOG35-
55-primed WT and NG2KO T-cell cultures by ELISA 
Standard Set kits (IL-4, IL-17 and IL-10 ELISA MAX, 
Biolegend; IFN-γ, Mabtech). Briefly, 96-well ELISA 
plates coated overnight with appropriate capture antibodies 
at 4 °C were washed with PBS supplemented with 0.1 % 
Tween 20 and blocked with PBS containing 5 % FBS for 
2 h at room temperature. Supernatants of cell cultures 
(100 μl) were added and the plates were incubated for 2 h 
at room temperature. Plates were washed and incubated 
with the relevant horseradish peroxidase-coupled detection 
antibodies for 1 h at room temperature. The plates were 
washed, substrate (3,3′,5,5′tetramethylbenzidine, Sigma-
Aldrich) was added, and the plates were developed for 
20–30 min. The reaction was stopped with 2 N H2SO4 and 
plates read at OD 450 nm on a Multilabel Victor3 reader 
(Perkin Elmer).
Generation and activation of bone‑marrow‑derived 
dendritic cells
Primary bone-marrow-derived dendritic cells (BMDDCs) 
were obtained as described previously [6]. Briefly, at day 
0, bone-marrow cells from WT and NG2KO mice were 
flushed from the femur and tibia and passed through a 
70-µm nylon cell strainer (Becton–Dickinson, New Jersey, 
USA). The cell suspension was seeded in the presence of 
granulocyte macrophage colony-stimulating factor (20 ng/
ml, Miltenyi) and after seven days, the cells were analyzed 
by FACS for surface marker CD11c. Purity of CD11c+ 
cells assessed by FACS with APC-conjugated anti-CD11c 
antibody (Becton–Dickinson) was at least 65 %. Activa-
tion of CD11c+ BMDDCs was then carried out by stimu-
lation for 24 h with 10 μg/ml lipopolysaccharide (LPS, 
Sigma-Aldrich).
Generation and polarization of bone‑marrow‑derived 
macrophages
To generate primary bone-marrow-derived macrophages 
(BMDMs), bone-marrow cells were flushed from the 
femur and tibia and passed through a 70-µm nylon cell 
strainer (Becton–Dickinson). The cell suspension was 
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seeded in 6-well plates (6 × 106/well) in the presence 
of macrophage colony-stimulating factor (100 ng/ml, 
Miltenyi) in Minimum Essential Medium alpha (Thermo 
Fisher Scientific) with 1 % penicillin/streptomycin (50 U/
ml) and 10 % FBS. After 7 days, polarization of WT and 
NG2KO BMDMs towards M1 and M2 phenotypes was 
performed for 72 h by stimulation with IFN-γ (20 ng/ml, 
R&D Systems) or with IL-4 (20 ng/ml, R&D Systems), 
respectively. Polarization to the appropriate phenotype 
was confirmed by FACS analysis for the expression of 
M1- and M2-specific surface maturation markers (see 
below).
FACS analysis
Surface marker staining and intracellular cytokine stain-
ing were performed using the Cytofix/Cytoperm, Fixa-
tion/Permeabilization Solution Kit (Becton–Dickinson), 
according to the manufacturer’s protocol. Briefly, cells 
(5 × 105) were resuspended in 100 µl of FACS buffer 
(PBS, pH 7.2, containing 0.5 % bovine serum albumin) 
and stained with appropriate conjugated antibodies for 
30 min at 4 °C.
To assess the NG2 expression on immune cells, sple-
nocytes were isolated, passed through a 70-µm nylon cell 
strainer (Becton–Dickinson) to prepare a single-cell sus-
pension, and used to optimize staining conditions. To estab-
lish background staining and to check the positive signal 
using the appropriate amount of anti-NG2 Alexa Fluor®488 
antibody (diluted 1:100, Merck), we performed a limited 
set of pilot experiments where quadrants were set based 
on staining with isotype-matched control antibody and 
NG2KO splenocytes were tested as negative control. WT 
splenocytes were double-stained with anti-NG2 antibody 
and antibodies against relevant surface markers, PE-con-
jugated anti-CD3 (diluted 1:100, Biolegend), APC-conju-
gated anti-CD11c, and PE-conjugated anti-CD11b (diluted 
1:100, Becton–Dickinson) antibodies, for T cells, DCs, and 
macrophages, respectively.
BMDMs from WT and NG2KO mice were assessed by 
FACS for surface-specific markers of macrophage matu-
ration using PercP-conjugated anti-CD86, PE-conjugated 
anti-CD206 (diluted 1:100, both from Biolegend) and PE-
conjugated anti-MHCII (diluted 1:100, Becton–Dickinson) 
antibodies. WT and NG2KO LPS-primed BMDDCs and 
MOG35–55-stimulated lymph node cells were incubated 
with APC-conjugated anti-CD11c antibody (diluted 1:100, 
Becton–Dickinson) for 30 min at 4 °C, fixed/permeabilized 
for 15 min at 4 °C, and processed for intracellular cytokine 
staining using PE-conjugated anti-IL-12 (p70) antibody 
(diluted 1:100, BD Pharmingen) for 30 min at 4 °C. Data 
were acquired on a FACS Canto II (Becton–Dickinson) and 
analyzed using DIVA 6.1 software.
Real‑time PCR
Total RNA was isolated using TRIzol® Reagent (Thermo 
Fisher Scientific). First-strand cDNAs were generated start-
ing from 1 μg RNA using Transcriptor First Strand cDNA 
Synthesis Kit (Roche). Real-time PCR was performed with 
20 ng cDNA using a Roche Light Cycler 480 (Roche). 
Experiments were performed in triplicates, with glyceral-
dehyde 3-phosphate dehydrogenase (Gapdh) analyzed as 
housekeeping gene to normalize the expression data. The 
relative gene expression of target genes in reference to 
Gapdh expression was analyzed using the comparative CT 
threshold method [41], and the normalized expression was 
expressed as fold induction over the control sample. The 
following forward and reverse primers (TIB MOLBIOL) 
were used: Il12, forward primer: 5′-GGAGTCCAGTCC 
ACCTCTACA-3′, reverse primer: 5′-ATCGTTTTGCTGG 
TGTCTCC-3′; Tnf, forward primer: 5′-GGTCTGGGCC 
ATAGAACTGA-3′, reverse primer: 5′-TCTTCTCATTCC 
TGCTTGTGG-3′; Nos2, forward primer: 5′-TTCATG 
ATAACGTTTCTGGCTCT-3′, reverse primer: 5′-TGAACT 
TGAGCGAGGAGCA-3′; Chil3, forward primer: 5′-GAG 
ACCATGGCACTGAACG-3′, reverse primer: 5′-AAG 
AACACTGAGCTAAAAACTCTCCT-3′; Arg1, forward 
primer: 5′-GAATCCTGGTACATCTGGGAAC-3′, reverse 
primer: 5′-GAATCTGCATGGGCAACC-3′; Ifng, forward 
primer: 5′-TTCAAGACTTCAAAGAGTCTGAGG-3′, reverse 
primer: 5′-GGAGGAACTGGCAAAAGGAT-3′; Il1b, 
forward primer: 5′-TTTGAAGCTGGATGCTCTCAT-3′, 
reverse primer: 5′-AGTTGACGGACCCCAAAAG-3′; Sox, 
forward primer: 5′-AGCCTCATCGGAGGGCTA-3′, reverse 
primer: 5′-AGGCAACTGCAGGCTGTAAAA-3′; Gapdh: 
forward primer: 5′-AATCTCCACTTTGCCACTGC-3′, 
reverse primer: 5′-ATGGTGAAGGTCGGTGTGA-3′.
Generation of chimeric mice
To create bone marrow chimera, female WT and NG2KO 
recipient mice (8 weeks of age) were irradiated with a 
lethal dose (9.5 Gy) and immediately transplanted with 
bone-marrow cells (5 × 106 per mouse in 100 µl of PBS 
injected in the tail vein) isolated from hind legs of synge-
neic 8-week-old donor male mice. Reconstitution in the 
recipient was evaluated 8 weeks later by real-time PCR for 
sex-determining region Y (Sox) gene [37] in circulating 
leucocytes. To avoid host infections, 50 mg/ml Gentamicin 
(Sigma-Aldrich) was added to the drinking water, 1 week 
before irradiation and for 2 weeks thereafter.
Statistical analysis
The results were analyzed with GraphPad Prism software 
(version 6.01; GraphPad Software). Intergroup differences 
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were analyzed by one-way ANOVA followed by Bonfer-
roni’s post hoc test. Comparison of two sets of data used 
the Mann–Whitney test. Differences between groups were 
considered to be significant when P ≤ 0.05 (*), P ≤ 0.01 
(#) and P ≤ 0.0001 (**).
Results
NG2KO mice develop milder EAE than their WT 
counterparts
Figure 1a (left panel) shows a representative clinical 
course of EAE in WT and NG2KO mice. While both 
groups exhibited a chronic course of EAE, there were 
major differences in incidence, onset, and clinical sever-
ity. In the three experiments performed (total n = 33 WT 
and 35 NG2KO), disease incidence was lower in NG2KO 
mice (84 ± 4.5 vs. 100 % in WT mice) and disease 
onset was delayed (13.06 ± 3.66 vs. 8.16 ± 1.71 days 
for WT mice). Most importantly, the disease followed a 
significantly less severe course in NG2KO mice than in 
WT mice throughout the 40-day monitoring period, as 
assessed by measurement of the area under the curve 
(AUC; Fig. 1a, right panel). Histological examination of 
CNS tissue at the chronic stage of the disease (day 40 
post-immunization) showed significantly reduced demy-
elination in the spinal cord of NG2KO mice (Fig. 1b), 
which was accompanied by lower numbers of inflamma-
tory cells in the CNS (Fig. 1c, d and Supplementary Fig. 
S2). Thus, a decrease in perivascular extravasation of leu-
kocytes (CD45+ cells), possibly macrophages, in NG2KO 
mouse brain was observed by confocal microscopy 
(Fig. 1c). Similarly, the numbers of IBA-1+ and iNOS+ 
cells, most likely microglia, were reduced by two- to 
fourfold in the spinal cord of NG2KO mice (Fig. 1d and 
Supplementary Fig. S2) and GFAP+ reactive astrocytes 
were significantly decreased in EAE-affected NG2KO 
mice compared to WT controls (Fig. 1d). At this chronic 
stage of the disease, there was no difference in the num-
ber of infiltrated T cells (CD3+) in CNS of EAE-affected 
NG2KO as compared to WT mice (Fig. 1d). These results, 
therefore, show that actively induced EAE is considera-
bly attenuated in NG2-deficient mice, both at clinical and 
neuropathological levels, and contrast with those of a pre-
vious study in which NG2 was found to be dispensable 
for EAE [35].
EAE‑associated neuroinflammation is less intense 
in spinal cord of NG2KO mice
We sought to evaluate if the decreased numbers of inflam-
matory cells in EAE-affected NG2KO CNS reflected on 
the inflammatory milieu of EAE-affected WT vs NG2KO 
CNS by measuring mRNA expression of EAE-relevant 
pro-inflammatory cytokines, Ifng, Tnf, Il1b, and Il12. The 
expression of all four genes did not differ in naïve WT vs 
NG2KO spinal cord and greatly increased in both WT and 
NG2KO at the early phase of EAE as expected (Fig. 1e). 
However, the expression of the four genes in EAE was 
lower in NG2KO spinal cord than that in WT spinal cord 
(Fig. 1e), with significant differences observed for Ifng, 
Il1b, and Il12, confirming that the CNS environment in 
EAE-affected NG2KO mice is characterized by reduced 
inflammation, as compared to that of EAE-affected WT 
mice.
OPC numbers do not change in NG2KO brain 
during EAE
We have previously shown that in WT mice, the progres-
sive process of demyelination was accompanied by a strong 
reduction in the number of OPCs at the chronic EAE phase 
(39 days post-induction) after a significant increase at the 
early EAE phase [16]. To analyze whether the lack of NG2 
affected this important response of the oligodendrocyte cell 
Fig. 1  NG2KO mice develop milder EAE than their WT counter-
parts. a MOG-induced EAE follows a less severe course in NG2KO 
mice. A representative of three independent experiments is pre-
sented (WT, n = 17; NG2KO, n = 19. Total mice tested in three 
experiments: WT, n = 33; NG2KO, n = 35). Data are shown as 
mean ± SEM daily clinical score (left panel) and mean ± SEM area 
under the curve (AUC) of EAE clinical course calculated for each 
mouse (right panel). **P < 0.0001. b Demyelination is decreased 
in NG2KO mouse CNS. Demyelinated areas were quantified by 
Luxol Fast Blue staining for myelin in spinal cord sections from 
WT and NG2KO EAE-affected mice (3 sections per each of cervi-
cal, thoracic and lumbar regions per mouse, n = 5 mice per group) 
sampled at chronic disease phase, 40 days post EAE induction. Data 
are expressed as mean ± SEM percent of demyelination (weakly 
stained area over strongly stained area in all spinal cord sections 
assessed × 100). #P < 0.01. c Representative confocal microscopy 
images showing perivascular infiltration of CD45+ cells in WT and 
NG2KO brain. In EAE-affected WT mice (40 days post induction), 
an inflammatory infiltrate is evidenced around microvessel stained 
for collagen IV (Coll IV) as a component of the basement membrane, 
whereas in EAE-affected NG2KO mice, perivascular CD45-positve 
cells are rarely observed (Coll IV, green; CD45, red). Scale bar 20 
μm. d Quantification of confocal microscopy data shows a decrease 
in inflammatory cells, but not infiltrating T cells in NG2KO mouse 
CNS. Spinal cord sections as in b were stained for the presence of 
microglia/macrophages (IBA-1), activated astrocytes (GFAP), stress 
marker-positive cells (iNOS), and infiltrating T-cells (CD3). Data are 
presented as mean ± SEM positive cell number/mm2. **P < 0.0001. 
e In EAE, the NG2KO phenotype is associated with decreased 
expression levels of pro-inflammatory cytokines in the CNS. Real-
time PCR analysis of mRNA expression of genes associated with 
inflammation in EAE spinal cord. mRNA was obtained from whole 
spinal cord samples collected at early-disease phase, 6 days after dis-
ease onset. Data are presented as mean ± SEM fold induction over 
naïve WT value of 3 independent experiments. *P < 0.05
▸
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lineage, we quantified the number of OPCs in both WT and 
NG2KO mice by immunofluorescence confocal micros-
copy. We first verified the concomitant expression of NG2 
and an alternative OPC marker, platelet-derived growth 
factor receptor-α (PDGFRα), in WT OPCs [28] to validate 
the subsequent quantification of OPCs in NG2KO mice 
(Supplementary Fig. S3a, left panel). We assessed the lack 
of NG2 expression in NG2KO OPCs by NG2/PDGFRα 
double-labeling (Supplementary Fig. S3a, right panel), as 
well as in NG2KO brain microvessels by double-staining 
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for NG2 and the pericyte marker CD13 (Supplementary 
Fig. S3b). As expected from our PCR analysis, which con-
firmed the gene disruption in our mice (Supplementary 
Fig. S1), no NG2-specific signal was detected in the CNS 
of NG2KO mice, either in OPCs or in pericytes (Supple-
mentary Fig. S3a and b). Quantification of cell numbers, 
based on confocal microscopy computer-aided morphom-
etry (Fig. 2a, left panel), showed no significant differences 
in PDGFRα+ OPCs in naïve WT and NG2KO mice. Dur-
ing EAE, the number of OPCs in brain and spinal cord 
showed an increase at 20 dpi and a significant decrease 
at 40 dpi in WT mice, as expected [16]. In contrast, OPC 
numbers remained constant in NG2KO mice throughout 
the disease (Fig. 2a right panel and Supplementary Fig. 
S3c). These results suggest that the lack of NG2 on OPCs 
may not only affect their proliferative ability and/or their 
differentiation to pre-myelinating oligodendrocytes, but 
also may reduce OPC apoptosis during the chronic phase 
of EAE, possibly due to a less inflammatory CNS milieu in 
these mice. Evaluation of GPR17+ pre-myelinating oligo-
dendrocytes (Fig. 2b) indicated a parallel with our obser-
vations for OPCs. Thus, while in EAE-affected WT mice 
GPR17+ pre-myelinating oligodendrocytes increased at 
20 dpi and decreased sharply at 40 dpi, their numbers did 
not change in NG2KO EAE-affected mice (Fig. 2b, right 
panel), suggesting that the lack of NG2 does not affect the 
differentiation ability of NG2KO OPCs. A reduced loss of 
pre-myelinating oligodendrocytes together with reduced 
inflammation and demyelination might suggest that axonal 
loss could also be lower in NG2KO mice. Indeed, we 
observed that, while axonal damage increased in WT EAE-
affected mice throughout the disease, the number of dam-
aged axons was markedly lower in NG2KO mice at the 
chronic phase (Fig. 2c).
The preserved continuity of tight‑junction protein 
distribution in EAE NG2KO CNS is associated with an 
efficient blood–brain barrier function
Because NG2+ pericytes play an important role in the for-
mation of the neurovascular unit and BBB, we sought to 
evaluate if the reduced level of neuroinflammation in EAE-
affected NG2KO mice could be related to specific altera-
tions in the BBB. Thus, we investigated the distribution of 
the major structural and functional proteins of endothelial 
tight-junction (TJ), claudin-5 and occludin [12], in cerebral 
cortex and spinal cord microvessels of WT and NG2KO 
mice by immunofluorescence confocal microscopy. On 
confocal projection images of naïve WT BBB microves-
sels, the fundamental arrangement of claudin-5/occludin 
at the junctional membranes formed a ribbon-like regular 
and continuous staining pattern, which was lost in EAE-
affected WT mice where it changed to a discontinuous one, 
characterized by claudin-5/occludin-reactive short tracts 
and punctate rows ([11] and Fig. 3a, b). In naïve NG2KO 
mice, the staining for claudin-5 and occludin, while con-
tinuous, was characterized by thin lines and focal spots 
(Fig. 3a, b and Supplementary Fig. S4). In EAE-affected 
NG2KO mice compared with EAE-affected WT mice, 
claudin-5 and occludin staining patterns were preserved 
and in some microvessels appeared even more regular than 
in naïve NG2KO mice, being formed by claudin-5/occlu-
din-reactive wide junctional strips along the entire length 
of the microvessels examined (Fig. 3a, b and Supplemen-
tary Fig. S4). In agreement with the described continuous 
staining pattern, purported to represent the sealing function 
of TJ strands, a preserved barrier function, as demonstrated 
by Dextran-FITC experiments, was observed in naïve and 
EAE-affected NG2KO mice (Fig. 3c). Indeed, disruption 
of BBB-endothelial cell TJs and leakage of the perme-
ability tracer described in cerebral cortex and spinal cord 
microvessels of EAE-affected WT mice ([11] and Fig. 3c, 
upper right panel) was never seen in naïve or EAE-affected 
NG2KO mice, the fluorescent Dextran-FITC signal being 
always restricted to the vessel lumen (Fig. 3c, lower left 
and right panel, respectively). Overall, these results empha-
size the barrier efficiency to the exogenous tracer of the 
continuous distribution of TJ proteins in naïve and EAE-
affected NG2KO mice. We suggest that in NG2KO mice, 
Fig. 2  Decrease in OPCs at EAE chronic stage does not occur in 
NG2KO mice. a OPCs quantified by confocal microscopy morpho-
metry on brain PDGFRα-stained sections (left panel) show a sharp 
decrease in EAE-affected WT mice at the chronic disease stage, 
while their number remains constant in EAE-affected NG2KO mice 
throughout the disease (right panel). OPCs were quantified in cer-
ebral cortex of naïve and EAE mice (4 sections per mouse, n = 5 
mice per group) by counting PDGFRα+ cells, as justified by confo-
cal microscopy data that confirmed the co-localization of NG2 and 
PDGFRα in WT mouse brain (Supplementary Fig. S3a). Similar 
results were obtained from the quantification of OPCs in spinal cord 
(Supplementary Figure S3c). Scale bars 25 μm. Data are presented 
as mean ± SD cell number/mm3. *P < 0.05, #P < 0.01. b Numbers 
of pre-myelinating oligodendrocytes do not change in NG2KO mice 
throughout EAE. Pre-myelinating oligodendrocytes were quanti-
fied in cerebral cortex of naïve and EAE mice (4 sections per mouse, 
n = 4 mice per group) by staining for GPR17 and counting only 
highly ramified GPR17+ cells. This is justified through confocal 
microscopy of naïve WT tissue stained concomitantly for PDGFRα, 
which shows that pre-myelinating highly ramified cells with broad 
GPR17 expression (left panel, arrows) do not express PDGFRα, 
whereas GPR17 expression in PDGFRα+ OPCs appears as single 
intracellular spots (left panel, arrow heads) [4]. Data (right panel) 
are presented as mean ± SD cell number/mm3. **P < 0.0001. Scale 
bar 75 μm. c The extent of axonal damage at EAE chronic phase is 
reduced in NG2KO CNS. Nerve fibers were localized by MBP reac-
tivity and damaged axons were quantified as APP+ transversely cut 
axons (left panel) in spinal cord white matter of naïve and EAE mice 
(4 sections per mouse, n = 4 mice per group). Data (right panel) are 
presented as mean ± SD axon number/mm2. *P < 0.05, #P < 0.01, 
**P < 0.0001. Scale bars 10 μm. All quantifications were performed 
at both early (20 dpi) and chronic (40 dpi) disease phases
◂
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the lack of NG2 on pericytes affects the dynamic assembly 
of TJs, and upon pericyte activation during EAE, alterna-
tive signaling transduction pathways involved in TJ main-
tenance are triggered that result in the targeting of TJ mol-
ecules to the TJ.
NG2 is expressed by immune cells
In the injured CNS, in addition to OPCs and pericytes, NG2 
is expressed by invading macrophage-like cells [5, 28, 33]. 
The possibility was raised that NG2 null macrophages may 
Fig. 3  The preserved continuity 
of tight-junction protein distri-
bution in CNS of EAE-affected 
NG2KO mice is associated with 
an efficient blood–brain barrier 
function. a, b Confocal micros-
copy images of cerebral cortex 
immunostained for claudin-5 
and occludin in naïve and EAE-
affected WT and NG2KO mice 
at chronic disease stage (40 
dpi). In naïve WT mice, stain-
ing for claudin-5 and occludin 
shows a continuous, linear, 
and regular pattern, whereas 
in EAE-affected WT mice the 
staining pattern is discontinu-
ous, characterized by thin tracts 
and unlabeled gaps (arrows). In 
naïve NG2KO mice, clau-
din-5 and occludin reactivity 
appears continuous although 
irregular, with thin fluorescent 
tracts alternating with points of 
focal staining; in EAE-affected 
NG2KO mice, the junctional 
immunostaining is continuous 
and regular (arrowheads). c 
Confocal microscopy images of 
cerebral cortex of mice injected 
with FITC-dextran confirms 
the preserved BBB function in 
EAE-affected NG2KO mice. 
FITC-dextran leakage in EAE-
affected WT mice (arrow) is 
not observed in EAE-affected 
NG2KO mouse brains. Nuclei 
are stained with TO-PRO-3 
(blue). Scale bars a 20 μm; 
b 10 μm; and c 30 μm. The 
binary image rendering shown 
in the right panels emphasizes 
the changes in expression of 
tight-junction proteins among 
all the experimental groups 
and the discontinuity of the 
EAE-affected WT pattern vs the 
EAE-affected NG2KO pattern, 
as well as the diffuse leakage in 
EAE-affected WT mouse brain
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exhibit less inflammatory properties than their WT counter-
parts [28], leading to a reduced ability to invade the CNS 
[30], and such a feature would support the lower extent of 
inflammation in NG2KO CNS during EAE. To determine 
if the possible role of NG2 in inflammation might also 
be relevant for other inflammatory cells that are liable to 
infiltrate the CNS during EAE [7, 56], we sought to ascer-
tain whether NG2 is expressed in WT mice or not by cells 
of the systemic immune system. We assessed the expres-
sion of NG2 by T cells in freshly isolated splenocytes and 
by bone-marrow-derived dendritic cells (BMDDCs) and 
macrophages (BMDMs). As can be seen in Fig. 4, confo-
cal microscopy analysis with antibodies against mark-
ers of T cells (CD3), BMDDCs (CD11c), and BMDMs 
(CD11b) showed that each of these cell types expressed 
NG2 (Fig. 4a), and quantification by FACS revealed 
that the majority of T cells and BMDMs were NG2+, 
whereas around 50 % of BMDDCs expressed it (Fig. 4b). 
Similar data were obtained for CD11c+ and CD11b+ cells 
in freshly isolated splenocytes (data not shown). These data 
suggest that the decreased EAE pathology in NG2KO mice 
might not only be caused by differences at the CNS and 
BBB levels, but could also be related to the lack of NG2 
expression on disease-relevant immune cells.
The encephalitogenic T‑cell response to MOG 
in NG2KO mice is shifted towards a less inflammatory 
profile
To determine if the lack of NG2 on immune cells could 
impact disease expression in NG2KO mice, we compared 
T-cell proliferation and cytokine expression in response to 
the encephalitogenic peptide. Lymph node cells, isolated 
from WT and NG2KO mice primed 9 days previously with 
MOG35–55, were assessed for their ex vivo recall prolifer-
ation to MOG35-55 and to positive (mitogenic stimulation 
Fig. 4  NG2 is expressed by immune cells. a Confocal microscopy 
images demonstrate the expression of NG2 (green) in T cells (CD3, 
red, left panel), dendritic cells (CD11c, red, middle panel), and mac-
rophages (CD11b, red, right panel) within WT splenocytes. Scale bar 
5 μm. Magnification ×100. Confirmation of the lack of NG2 expres-
sion on NG2KO immune cells, and thereby the specificity of the anti-
NG2 antibody, is presented in Supplementary Fig. S5. b FACS analy-
sis confirms that the majority of mouse T cells and macrophages, as 
well as a large proportion of dendritic cells, express NG2. Quantita-
tive histogram of NG2 expression on WT T cells (CD3) freshly iso-
lated from spleen, and in vitro-differentiated BMDDCs (CD11c) and 
BMDMs (CD11b). Data are presented as mean ± SEM of four inde-
pendent experiments
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with ConA) and negative (stimulation with PLP139-151, 
another myelin antigen) T-cell stimuli. Cells isolated 
from WT and NG2KO mice proliferated equally well to 
MOG35–55 (Fig. 5a), suggesting that the antigen-specific 
proliferative response is not dependent on NG2 expression 
on T cells. The mitogenic response to ConA by WT cells 
was generally higher than that by NG2KO cells, and we 
can only speculate that this might be related to increased 
activation of WT T cells upon binding by ConA not only 
to the CD3, but also to NG2 [22, 34, 36]. In contrast, the 
cytokine profile of MOG35-55 reactive WT and NG2KO T 
cells differed significantly. As can be seen in Fig. 5b, the 
concentration measured by ELISA of the pro-inflammatory 
Th1-like cytokine, IFN-γ, was significantly lower in super-
natants of the 3-day ex vivo recall response to MOG35–55 
by NG2KO T cells, whereas those of the anti-inflammatory, 
Th2-type cytokines, IL-4 and IL-10, were significantly 
elevated, as compared to WT cells. IL-17a levels did not 
differ.
These findings suggest that in NG2KO mice, the T-cell 
response to the encephalitogenic MOG35-55 is skewed 
towards a Th2-cell response, which is notoriously associ-
ated with reduced encephalitogenicity and/or contributes to 
disease recovery.
IL‑12 expression is reduced in stimulated NG2KO DCs. 
Role of NG2 in DC activation
The cytokine shift of encephalitogenic NG2KO T cells is 
unlikely to be a feature intrinsic to these T cells themselves, 
as there was no difference in cytokine profile of MOG35–
55-specific T-cell lines generated from WT and NG2KO 
mice (Supplementary Fig. S6). To assess whether it could 
instead be related to their stimulation upon antigen presen-
tation, we investigated the expression of IL-12, the cytokine 
involved in the differentiation of naïve T cells into Th1 
cells, by activated NG2KO DCs as compared to their WT 
counterparts. BMDDCs were stimulated or not with LPS 
and IL-12 expression was assessed by real-time PCR and 
intracellular FACS analyses (Fig. 6a, b). There was a signif-
icant decrease in IL-12 mRNA expression by three to four-
folds in NG2KO BMDDCs (Fig. 6a) that was corroborated 
Fig. 5  Lack of NG2 on T cells does not affect their antigen-specific 
proliferation but affects their cytokine profile. a Ex vivo analysis 
of the recall response by lymph node cells isolated from MOG35-
55-primed WT and NG2KO mice 9 days post-immunization. Data 
of proliferation to MOG35-55 (MOG, 10 μg/ml) are presented as 
mean ± SEM incorporated EdU of three independent experiments. 
Response to concanavalin A (ConA, 5 μg/ml) and proteolipid protein 
peptide 139–151 (PLP, 10 μg/ml) are presented as positive and nega-
tive controls for the assay, respectively. **P < 0.001. b The cytokine 
profile of NG2KO lymph node cells in response to MOG is shifted 
towards a non-inflammatory type as compared to WT cells. Super-
natants from the 3-day proliferation assays in (a) were assessed by 
ELISA for their cytokine contents. A representative of the three inde-
pendent experiments is shown. Data are presented as mean ± SEM 
cytokine concentration of quadruplicate supernatant samples. 
*P < 0.05
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by a parallel decrease at the protein level (Fig. 6b), indicat-
ing that NG2KO DCs are less capable of inducing a Th1 
response than WT DCs. To assess if this in vitro feature of 
NG2KO DCs reflected the in vivo situation, we immunized 
WT and NG2KO mice for EAE, isolated CD11c+ cells 
from the draining lymph nodes 7 days later, and analyzed 
their IL-12 expression by intracellular FACS. As can be 
seen in Fig. 6c, the proportion of IL-12-expressing CD11c+ 
cells was significantly decreased in MOG35-55-primed 
NG2KO lymph node cells as compared to WT. Whether 
this might be due to an inherent lower expression of the 
cytokine or to a reduced migration of the DCs to the lymph 
nodes in NG2KO mice is unclear at this stage, but suggests 
that these cells might be less effective to induce in vivo dif-
ferentiation to Th1 cells. Based on these data and our obser-
vation that 50 % of CD11c+ cells express NG2 (Fig. 4b), 
we wondered if the expression of IL-12 by DCs might be 
related to their expression of NG2. Accordingly, we quanti-
fied the percent of NG2+ and NG2− CD11c+ cells in the 
IL-12-gated population of lymph node cells isolated from 
MOG35-55-primed WT mice. Interestingly, the proportion 
of IL-12-expressing cells was very low in CD11c+ cells 
that did not express NG2 and significantly lower than that 
in NG2+ CD11c+ cells (Fig. 6d). Altogether, these data 
suggest that NG2 expression associates with the ability 
of DC to produce sufficient amounts of IL-12 to properly 
prime encephalitogenic Th1 cells.
NG2 is not involved in macrophage polarization
Our demonstration that the number of cells positive for 
IBA-1, marker for activated microglia/macrophages, was 
significantly lower in CNS of EAE-affected NG2KO 
mice (Fig. 1d) suggested the possibility that, in addition 
to decreased microglia activation, the number of infiltrat-
ing activated macrophages was lower in these mice during 
EAE, as also supported by a decreased number of perivas-
cular CD45+ cells (Fig. 1c). While this observation could 
Fig. 6  The expression of IL-12 is reduced in NG2KO DCs. a Real-
time PCR and b intracellular FACS analyses show reduced expres-
sion of IL-12 in LPS-stimulated BMDDCs from naïve NG2KO 
mice. BMDDCs seeded in 6-well plates (7.5 × 106 cells/well) were 
stimulated with LPS (10 µg/ml) for 24 h. Real-time PCR data are pre-
sented as mean ± SEM fold increase over unstimulated cells of three 
independent experiments; *P < 0.05. FACS plots of a representa-
tive of three independent experiments are presented. c Lack of NG2 
on DCs isolated from lymph nodes in MOG35–55-primed NG2KO 
mice leads to their reduced expression of IL-12. Lymph node cells 
isolated from WT and NG2KO mice primed with MOG35–55 7 days 
before were analyzed by FACS for concomitant expression of sur-
face CD11c and intracellular IL-12. Quantitative data are presented 
as mean ± SEM % of IL-12-expressing CD11c+ cells of three inde-
pendent experiments. d In WT mice, the proportion of IL-12-ex-
pressing cells is lower in CD11c+ cells that do not also express NG2. 
MOG35–55-primed WT lymph node cells as in (c) were stained con-
comitantly for intracellular IL-12, NG2, and CD11c and analyzed 
by FACS. The CD11c+ cells within the IL-12-gated population were 
analyzed for their NG2 expression. Quantitative data are presented as 
mean ± SEM % of IL-12-gated cells that expressed CD11c and were 
NG2+ or NG2−, for 3 independent experiments
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be secondary to the integrity of the BBB we observed in 
NG2KO mice, and to a decreased interaction of invading 
macrophages with endothelial adhesion molecules that are 
needed for extravasation [30], it could also be related to a 
defect in macrophage activation and polarization. Such 
a possibility would also impact on antigen-presenting 
function of NG2KO macrophages and, therefore, on the 
encephalitogenicity of the T-cell response. Accordingly, 
we sought to determine whether NG2 plays a role or not in 
macrophage polarization. BMDMs were polarized towards 
the M1 or M2 phenotype by priming with IFN-γ or IL-4, 
respectively, and assessed for the expression of M1 and M2 
markers. As can be seen in Fig. 7a, FACS analysis for M1 
(CD86, MHCII) and M2 (CD206) surface markers did not 
reveal any difference in unprimed WT vs NG2KO BMDMs 
(M0), IFN-γ-primed WT vs NG2KO BMDMs (M1), or 
IL-4-primed WT vs NG2KO BMDMs (M2). Similarly, 
there were no differences in the mRNA expression of addi-
tional M1 (Tnf, Nos2) and M2 (Chil3, Arg1) markers by 
unprimed WT vs NG2KO BMDMs (M0), IFN-γ-primed 
WT vs NG2KO BMDMs (M1), or IL-4-primed WT vs 
NG2KO BMDMs (M2) (Fig. 7b). These results suggest 
that NG2 per se is not involved in the polarization process 
itself. However, obviously, studies on in vitro-cultured cells 
cannot exclude that the in vivo environment influences 
the polarization of macrophages in WT and NG2KO mice 
upon EAE induction.
Both a modified immune response and a conserved 
BBB are responsible for the milder EAE manifestations 
in NG2KO mice
Altogether, the above findings suggested that the effect of 
NG2KO on the immune response might be of prime rele-
vance in the attenuated clinical and pathological manifes-
tations of EAE displayed by NG2KO mice. To ascertain 
this possibility, we generated chimeric mice reconstituted 
with whole bone-marrow cells, in which the role of the 
CNS milieu during EAE could be distinguished from 
that of the immune cells. Thus, WT NG2-sufficient mice 
Fig. 7  Lack of NG2 does not affect macrophage polarization in vitro. 
a, b FACS and real-time PCR analyses show that the expression of 
M1 and M2 markers does not differ between WT and NG2KO polar-
ized BMDMs. WT and NG2KO BMDMs seeded in 6-well plates 
(6.0 × 106 cells/well) were stimulated or not with IFN-γ (M1) or 
IL-4 (M2) (both at 20 ng/ml) for 48 h. a FACS plots, representa-
tive of three independent experiments, of naïve (M0) and M1- and 
M2-polarized BMDMs stained for M1 (CD86, MHCII) and M2 
(CD206) surface markers; b mRNA expression of M1 (Tnf, Nos2) 
and M2 (Chil3, Arg1) markers in polarized BMDMs. Data are pre-
sented as mean ± SEM fold induction over M0 value, of three inde-
pendent experiments
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were irradiated to eradicate the recipient immune cells 
and then reconstituted with NG2KO bone-marrow cells, 
and vice versa with irradiated NG2KO mice being trans-
planted with WT NG2-expressing bone-marrow cells. 
Control mice included irradiated WT mice receiving WT 
bone-marrow cells and irradiated NG2KO mice receiving 
NG2KO bone-marrow cells. Two months after transplan-
tation, mice were immunized for EAE. As can be seen in 
Fig. 8a (left panel), while all groups developed disease at 
the same time, mice transplanted with NG2KO bone-mar-
row cells (NG2KO → WT and NG2KO → NG2KO) dis-
played lower clinical scores than mice transplanted with 
WT bone-marrow cells (WT → NG2KO and WT → WT); 
the clearly attenuated disease course in these groups was 
confirmed by statistical analysis of the AUC (Fig. 8a, right 
panel). The reduced clinical severity was accompanied by 
less severe neuropathology with reduced demyelination in 
recipients of NG2KO bone marrow (Fig. 8b). To analyze 
if reconstitution with the different immune systems had 
a differential effect on the BBB of the recipient mice, we 
analyzed the distribution of the endothelial TJ proteins, 
claudin-5 and occludin, in the chimera CNS microvessels. 
As shown in Fig. 8c, regardless of the donor bone marrow, 
the junctional staining patterns of EAE-affected WT recipi-
ent chimera were discontinuous, similar to that observed 
in EAE-affected WT mice (Fig. 3a), whereas in NG2KO 
recipient chimera interendothelial TJs appeared preserved 
as suggested by the continuous claudin-5/occludin staining 
pattern. These data indicate that the milder EAE observed 
in NG2KO mice results from both lower pathogenicity of 
NG2KO immune cells and a less leaky BBB in NG2KO 
recipients.
Discussion
In this study, we demonstrate that NG2, a marker of OPCs 
and pericytes, whose expression on various immune cell 
types we demonstrate here for the first time, plays an 
important role in the induction and progression of EAE. 
We further demonstrate that this role exerts itself at both 
the CNS/BBB and immune system levels. Thus, in EAE, 
the lack of NG2 resulted in reduced loss of OPCs at the 
chronic stage of EAE and in preserved TJ continuity, hence 
reduced BBB leakage, at the CNS level, and in a skewed 
Th2 response likely due to a shift of stimulating DCs to a 
less inflammatory profile. Our findings contrast markedly 
with those obtained by Moransard et al., who reported that 
NG2 expressed by CNS-resident cells or by infiltrating 
macrophages did not play a role in EAE [35]. The reasons 
for this discrepancy are unclear as both studies use NG2KO 
mice derived from the original colony generated by Grako 
et al. [17]. While the EAE induction protocols in the two 
studies differ, with the protocol used by Moransard et al. 
comprising less Mycobacterium tuberculosis per injec-
tion but including a boost after 7 days [35], the severity 
and course of the disease in the WT mice are equivalent in 
both studies. One can only speculate that the divergence 
in results might be attributable to differences in the mice 
themselves. The NG2 protein deficiency in these mice was 
obtained by homologous recombination to create a loss-of-
function mutation through disruption of the NG2 coding 
sequence via insertion of a neomycin-resistance fragment in 
the targeting vector [17]; it is, therefore, possible that muta-
tion rescue might occur, with loss of the insertion [20]. In 
this context, it is interesting to note that Moransard et al. did 
observe some NG2 reactivity of CNS resident cells in their 
NG2KO chimera reconstituted with WT bone marrow [35]; 
unfortunately, they do not show the data for their NG2KO/
NG2KO negative control chimera, nor do they show the 
confirmation of NG2 gene disruption in their NG2KO mice. 
We have verified the lack of NG2 in our NG2KO mouse 
colony through PCR analysis for the gene disruption (Sup-
plementary Fig. S1) and through immunochemistry both 
at the CNS (OPCs and pericytes, Supplementary Fig. S3a 
and b) and immune cell (Supplementary Fig. S6) levels. 
Our data are supported by previous data obtained in the 
focal demyelination/remyelination model induced in mouse 
spinal cord by intrathecal injection of lysolecithin, where 
reduced inflammation was associated with less myelin dam-
age and repair in NG2KO mice [28]. Indeed, in that study, 
naïve WT and NG2KO mice did not display differences 
in the numbers of PDGFRα+ OPCs, as we also observed; 
however, the acute demyelination stage (1 week after lysol-
ecithin injection) was associated with lower numbers of 
OPCs and macrophages in NG2KO spinal cord, together 
with a significantly lower number of demyelinated axons, 
as compared to WT mice [28]. We also observed a signifi-
cant reduction in demyelinated areas in spinal cord of EAE-
affected NG2KO mice at 40 dpi, which was associated with 
decreased inflammation. We have reported that at the acute 
phase of EAE, there is a significant increase in OPC num-
bers in WT mice [16]; this does not occur in NG2KO mice, 
where the OPC numbers do not change throughout the dis-
ease. While this could relate to enhanced differentiation of 
NG2KO OPCs to pre-myelinating oligodendrocytes, it is 
more likely due to the reported decreased OPC proliferation 
in the absence of NG2 [28, 29], as the levels of GPR17+ 
PDGFRα− cells paralleled those of OPCs in NG2KO mice 
throughout EAE, indicating that lack of NG2 is unlikely to 
alter OPC differentiation.
On par with the findings in lysolecithin-induced demy-
elination in NG2KO mice [28], we also observed a 
decreased expression of pro-inflammatory cytokines in 
CNS of EAE-affected NG2KO mice. These findings are 
further supported by our demonstration of the importance 
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of NG2 in immune cell function, leading to a skewing of 
the T-cell response to the encephalitogenic peptide from 
a Th1 to a Th2 type. Kucharova et al. have suggested that 
NG2KO macrophages/microglia exhibit less inflammatory 
properties than their wild-type counterparts [28], a possi-
bility supported by the in vitro demonstration that NG2KO 
microglia have a reduced inflammatory phenotype [13]. 
In vitro, Moransard et al. found that bone-marrow-derived 
macrophages, but not microglia, express low levels of NG2 
that increase significantly upon exposure to TGF-β [35]. 
In vivo, several studies have detected NG2 expression 
on macrophage-like cells in the injured CNS [5, 26, 33], 
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and Gao et al. observed colocalization of NG2 and OX42 
(CD11b/c) immunoreactivity in the corpus callosum of rats 
injected with LPS which elicits the innate immune response 
[13]. Similarly, Jones et al., using a combination of IBA-1 
immunolabeling and morphological analysis, identified 
macrophages, but not microglia, as cells producing NG2 
after spinal cord injury [26]. In EAE, Moransard et al. sug-
gest that there is overlap in macrophage distribution and 
NG2 immunoreactivity, albeit diffuse, in wild-type mice 
at the acute phase of the disease [35]. We have assessed 
the expression of NG2 on IBA-1+ macrophages/microglia 
in mice at 20 and 40 days after the encephalitogenic chal-
lenge and our results are in agreement with studies that 
showed the existence of a subpopulation of macrophage-
like NG2+ cells in the CNS after insult. Indeed, while we 
never detected NG2+ IBA-1+ cells in EAE CNS at 40 dpi, 
we observed the presence of a scarce NG2+ macrophage-
like population in the vicinity of EAE WT microvessels at 
20 dpi (data not shown). In our hands, day 20 after immu-
nization corresponds to the early chronic phase; it is, there-
fore, possible that we would have seen a greater number of 
NG2+ IBA-1+ cells at the acute phase, that is around days 
10–15, as Moransard et al. report, albeit without defining 
the time frame of the acute phase in their EAE model [35].
We show that not only macrophages but also T cells and 
dendritic cells express NG2 and that its absence results in a 
modified function of these cells. To our knowledge, expres-
sion of NG2 on peripheral blood and bone-marrow cells 
has not been reported before in mice, and NG2+ cells were 
only found in blood of patients with special types of leuke-
mia [38, 42, 43], using a monoclonal antibody, MoAb 7.1, 
raised against an SV-40-transformed human marrow stro-
mal cell line, which recognizes a 220–240 kDa protein with 
a high degree of homology to rat NG2 [43]. It is not clear 
why NG2 should be expressed on normal immune cells in 
mice and not in humans, and we can only speculate that in 
humans NG2 expression on hematopoietic cells is aberrant 
and induced by the disease, as suggested [38], or that the 
different observation might be due to the difference in anti-
bodies used. Indeed, in the present study we used a rabbit 
polyclonal antibody raised against purified rat NG2 and our 
FACS analysis of human peripheral blood cells from three 
control individuals with this polyclonal antibody shows 
that, in fact, human T cells, monocytes, and NK cells do 
express NG2 on their surface (Supplementary Fig. S8); it 
is, therefore, possible that the unique epitope recognized 
by MoAb 7.1 is masked in normal human blood cells and 
revealed only in modified human leukemic cells.
The potential role of NG2 expression on immune cells 
is unknown. Bu et al. suggest that its transient expression 
on macrophages invading the CNS upon excitotoxic hipoc-
campal lesioning is associated with an activated state of 
these cells [5]. However, we analyzed NG2 protein expres-
sion on non-activated cells freshly isolated from spleen 
or in vitro-derived from bone marrow and found that the 
majority of macrophages and T cells, and 50 % of den-
dritic cells express this molecule on their surface. As EAE 
is mediated by a T-cell response, mutations that affect T 
cells are likely to affect the T cell response and, therefore, 
the EAE course. In this context, we have observed a skew-
ing of encephalitogen-reactive NG2KO T cells from a Th1 
to a Th2 phenotype upon ex vivo recall response to MOG. 
Whether this is due to an intrinsic functional modification 
of NG2KO T cells or not is unclear. We have observed a 
strong upregulation of IL-4 mRNA expression in naïve 
NG2KO T cells as compared to WT T cells upon mitogenic 
stimulation, together with upregulation, albeit of a smaller 
extent, of IFN-γ and IL-17 mRNA (data not shown), sug-
gesting that skewing towards a Th2 type could be an intrin-
sic feature of NG2KO T cells.
Nevertheless, it is likely that the skewing from Th1 to Th2 
in MOG35-55-responsive NG2KO T cells is also related to 
a role of NG2 in DC activation. DCs are the main antigen-
presenting cells in EAE [18], co-infiltrating the CNS with T 
cells [7]; their production of IL-12 is essential in the Th1-cell 
response implicated in the disease. IL-12 is a potent inducer 
of IFN-γ secretion by T cells; it drives the differentiation of 
naïve T cells to Th1 cells while impeding that to Th2 cells, 
and contributes to amplification and expansion of Th1 cells. 
In EAE, the role of IL-12 in disease expression is clear; thus, 
treatment with recombinant IL-12 increased disease severity 
[31, 44] and in vitro treatment of encephalitogen-reactive T 
Fig. 8  Lack of NG2 expression at both CNS/BBB and immune sys-
tem levels contributes to the decrease in EAE severity observed in 
NG2KO mice. a Chimeric mice reconstituted with NG2KO bone-
marrow cells develop a milder EAE, regardless of their inherent 
WT or NG2KO genotype. Data are shown as mean ± SEM daily 
clinical score (left panel) and mean ± SEM AUC of EAE clinical 
course calculated for each mouse (right panel). #P < 0.01. A repre-
sentative of two independent experiments is presented (WT → WT, 
n = 10; NG2KO → WT, n = 10; NG2KO → NG2KO, n = 10; 
WT → NG2KO, n = 8). b Demyelination is decreased in CNS of 
NG2KO bone marrow recipients. Demyelinated areas were quan-
tified by staining for myelin basic protein in spinal cord sec-
tions from WT → WT, NG2KO → WT, NG2KO → NG2KO, and 
WT → NG2KO EAE-affected mice (three sections per each of cervi-
cal, thoracic, and lumbar regions per mouse, n = 3–4 mice per group) 
sampled at chronic disease phase, 40 days post EAE induction. Data 
are expressed as mean ± SEM percent of demyelination. *P < 0.05. 
c Confocal microscopy images of cerebral cortex immunostained 
for claudin-5 and occludin in EAE-affected chimera mice at chronic 
disease stage (40 dpi) confirm the maintenance of the BBB features 
in NG2KO recipient chimera regardless of the donor immune cell 
phenotype. In EAE-affected WT recipient mice, reconstituted with 
WT donor (WT → WT) or NG2KO donor ((NG2KO → WT) bone 
marrow, the junctional staining, for both claudin-5 and occludin, is 
characterized by a discontinuous pattern with long, unstained tracts, 
whereas the NG2KO recipient counterparts (NG2KO → NG2KO and 
WT → NG2KO) show a continuous junctional staining. Scale bars 
10 μm. Binary image rendering is shown in Supplementary Fig. S7
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cells with recombinant IL-12 enhanced their encephalito-
genicity upon adoptive transfer EAE [31, 54]. We observed 
a reduction in IL-12 expression by stimulated NG2KO DCs 
at both mRNA and protein levels and the expression of IL-
12-expressing CD11c+ cells was significantly decreased in 
MOG35-55-primed NG2KO lymph node cells; while this 
could be due to a decrease in migratory capacity of the DCs 
in NG2KO mice, possibly resulting from a stronger CD40 
signaling [32], it could also indicate that IL-12 expression is 
governed by NG2 expression by the cells. Our results, which 
show that, in naïve WT mice, the proportion of DCs that 
express IL-12 is significantly lower in NG2− than in NG2+ 
DCs, support this hypothesis. However, how NG2 expres-
sion influences the expression of IL-12 is unclear, and fur-
ther studies that include silencing the NG2 gene in WT DCs 
are necessary to sustain this possibility.
Our data on the role of NG2 in immune cell function 
suggest that NG2 KO results in less inflammatory T cells 
and DCs; while this could explain the reduced inflamma-
tory infiltration we see in NG2KO mice during EAE, the 
latter is also likely due to the lack of NG2+ pericytes and 
the maintained BBB in NG2KO mice during EAE. Thus, 
Stark et al. showed that NG2+, but not NG2−, pericytes 
interact dynamically with extravasated innate immune cells 
to promote their migration along capillaries and arteri-
oles [48]. Our observation of a maintained BBB in naïve 
NG2KO mice and its reinforced integrity during EAE 
was unexpected. Several studies on tumor vascularization, 
where NG2 expression is upregulated in activated peri-
cytes, have indicated that lack of NG2 results in reduced 
pericyte/endothelial cell interaction and basal lamina 
assembly with increased vessel leakiness [15, 25, 58]. 
However, CNS interendothelial TJs and BBB functionality 
had not been studied in healthy NG2KO mice until now. 
In our study, naïve NG2KO mice were viable, healthy, fer-
tile, and indistinguishable from WT mice, indicating that 
NG2 was not essential in BBB-microvessel development. 
Nevertheless, the modified appearance of the junctional 
staining pattern described in naïve NG2KO mice implies 
that NG2 is involved in the TJ settling plan and that its 
lack during brain development could lead to subtler altera-
tions of claudin-5 and occludin distribution. As revealed 
by freeze-fracture electron microscopy, TJ-associated inte-
gral membrane proteins form linear chains of particles, 
denoted TJ strands, which are arranged in regular meshes 
and correspond to focal attachments of the affronted junc-
tional membranes [45, 46, 51]. When considered in the 
context of strand organization, the aspect of naïve NG2KO 
TJs, upon claudin-5 and occludin immunostaining, may 
represent a reduced number of strands/meshes in the belt 
between two adjoining endothelial cells (bicellular TJs) 
and apparently normal points of intersections between 
three joining endothelial cells (tricellular TJs). The reason 
why vessel development is negatively impacted in tumors 
in the absence of NG2 may depend on a substantially dif-
ferent organization as compared to CNS microvessels. 
Thus, whereas tumor capillaries are built up from two cell 
types, pericytes and endothelial cells, the neurovascular 
unit typical of CNS microvessels is assembled from both 
cellular and non-cellular components, with the cellular 
component also including perivascular astrocytes that are 
thought to induce the barrier phenotype of endothelial cells 
[1, 8, 21]. Unlike that observed for NG2-expressing mac-
rophages in tumors, whose role prevails on NG2+ pericyte 
activity in determining vascular abnormalities (Yotsumoto 
et al. 2015), the results obtained through the analysis of 
EAE-affected NG2KO mouse chimeras confirm that TJ 
organization in CNS microvessels is primarily controlled 
by perivascular cells, astrocyte and pericytes. Thus, chi-
mera of NG2KO mice reconstituted with WT bone marrow 
and induced for EAE did not show increased leakiness as 
compared to their NG2KO counterparts reconstituted with 
NG2KO bone marrow.
In conclusion, we show that the lack of NG2 in NG2KO 
mice impacts EAE through its effect not only at the CNS 
level, more particularly at the BBB, but also most impor-
tantly at the immune response level. Our data further suggest 
that NG2, expressed on immune cells, might be involved in 
the activation of DCs and thereby of the encephalitogenic 
T-cell response, through controlling IL-12 expression.
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